Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3

Chemistry and Biology

Volumn 6, Issue 5, 1999, Pages 265-275

  Boehm, Marcus F ^a   Fitzgerald, Patrick ^a   Zou, Aihua ^a   Elgort, Marc G ^a   Bischoff, Eric D ^a   Mere, Lora ^a   Mais, Dale E ^a   Bissonnette, Reid P ^a   Heyman, Richard A ^a   Nadzan, Alex M ^a,b   Reichman, Melvin ^a   Allegretto, Elizabeth A ^a  

^a LIGAND PHARMACEUTICALS INC   (United States)

^b Chaugai Pharma USA   (United States)

Author keywords

Breast cancer; Leukemia; Prostate cancer; Vitamin D receptor

Indexed keywords

ANIMALIA;

EID: 0033133943     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(99)80072-6     Document Type: Article

References (38)

1. 1. Haussler, M.R. & McCain, T.A. (1977). Basic and clinical concepts related to vitamin D metabolism and action. N. Eng. J. Med. 297, 974-983, 1041-1050.
2. 2. DeLuca, H.F. (1988). The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J. 2, 224-236.
3. 3. Proc. Natl Acad. Sci. USA 76, 4990-4994.
4. 3. Proc. Natl Acad. Sci. USA 80, 5907-5911.
5. 3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J. Cell Biol. 98, 391-398.
6. 3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108, 1083-1086.
7. 3 receptor. Cancer Res. 44, 2103-2109.
8. 3 receptors and actions in human prostate cancer cell lines. Endocrinology 132, 1952-1960.
9. 3: a novel immunoregulatory hormone. Science 224, 1438-1440.
10. 3 and the immune system. Mol. Cell. Endocrinol. 43, 113-122.
11. 3, KH1060. Endocrinology 136, 866-872.
12. 3 attenuates the expression of experimental murine lupus of MRL/I mice. Autoimmunity 12, 143-148.
13. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis Proc. Natl Acad. Sci. USA 93, 7861-7864.
14. 3. J. Bone Min. Res. 6, 1021-1027.
15. 15. Haussler, M.R., et al., & Jurutka, P.W. (1998). The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res. 13, 325-349.
16. 16. Zugmaier, G., et al., & Knabbe, C. (1996). Growth-inhibitory effects of vitamin D analogs and retinoids on human pancreatic cancer cells. Br. J. Cancer 73, 1341-1346.
17. 3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line. Anticancer Res. 16, 2653-2660.
18. 1. Endocrinology 138, 1491 -1497.
19. 3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc. Natl Acad. Sci. USA 80, 201-204.
20. 3 in nude mice bearing transplantable human myelogenous leukemic cell lines. Exp. Hematol. 13, 722-732.
21. 21. Colston, K.W., Chander, S.K., Mackay, A.G. & Coombes, R.C. (1992). EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem. Pharmacol. 44, 693-702.
22. 3. Cancer Res. 47, 21-25.
23. 3 in chemically induced rat colon carcinogenesis. Carcinogenesis 13, 2293-2298.
24. 3 can be a safe and effective therapy for psoriasis. J. Amer. Acad. Dermatol. 19, 516-528.
25. 25. Bouillon, R., Okamura, W.H. & Norman, A.W. (1995). Structure-function relationships in the vitamin D endocrine system. Endocrine Rev. 16, 200-257.
26. 3 analogue (MC 903) in a double-blind study. Br. J. Dermatol. 119, 223-230.
27. 27. Dusso, A.S., et al., & Brown A.J. (1991). On the mechanisms for the selective action of vitamin D analogs. Endocrinology 128, 1687-1692.
28. 3. J. Biol. Chem. 272:19027-19034.
29. 3 analogs: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res. 55, 2822-2830.
30. 30. Collins, S.J., Ruscetti, F.W., Gallagher, R.E. & Gallo, R.C. (1979). Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J. Exp. Med. 149, 969-974.
31. 3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells. J. Immunol. 150, 3487-3495.
32. 3 and its 20-epi analogs (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines. Br. J. Pharmacol. 120, 1119-1127.
33. 33. Jones, K.T. & Sharpe, G.R. (1994). Intracellular free calcium and growth changes in single human keratinocytes in response to vitamin D and five 20-epi-analogs. Arch. Dermatol. Res. 286, 123-129.
34. 34. Bouillon, R., van Baelan, H. & de Moor, P. (1980). Comparative study of the affinity of the serum vitamin D-binding protein. J. Steroid Biochem. 13, 1029-1034.
35. 35. Baker, A.R., et al., & O'Malley, B.W. (1988). Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl Acad. Sci. USA 85, 3294-3298.
36. 36. McDonnell, D.P., Pike, J.W., Drutz, D.J., Butt, T.R. & O'Malley, B.W. (1989). Reconstitution of the vitamin D-responsive osteocalcin transcription unit in Saccharomyces cerevisiae. Mol. Cell. Biol. 9, 3517-3523.
37. 37. Allegretto, E.A., et al., & Heyman, R.A. (1993). Characterization of hormone-binding and transactivation properties of retinoic acid and retinoid X receptors. J. Biol. Chem. 268, 26625-26633.
38. 3. J. Biol. Chem. 270, 23906-23909.